Login / Signup

mRNA Therapies: New Hope in the Fight against Melanoma.

Melissa van DülmenAndrea Rentmeister
Published in: Biochemistry (2020)
Melanoma is a life-threatening disease caused by mutations in pigment-producing cells. Numerous treatments for melanoma have been approved in the past several decades; however, they often cause severe side effects and in most cases do not result in a complete cure. mRNA (messenger RNA) as a therapeutic agent provides a new avenue for melanoma treatment and several advantages over conventional treatments. The first mRNA drugs for melanoma treatment are currently in clinical trials, and approval of mRNA drugs by the Food and Drug Administration seems to be within reach. This new class of drugs can be readily adapted to other diseases, raising the hope of providing a new therapeutic option for various diseases.
Keyphrases
  • drug administration
  • skin cancer
  • clinical trial
  • binding protein
  • induced apoptosis
  • signaling pathway
  • climate change
  • human health